Literature DB >> 28479484

Interstital lung disease in ANCA vasculitis.

Marco A Alba1, Luis Felipe Flores-Suárez2, Ashley G Henderson3, Hong Xiao1, Peiqi Hu1, Patrick H Nachman4, Ronald J Falk4, J Charles Jennette5.   

Abstract

Anti-neutrophil cytoplasmic antibodies (ANCA) vasculitides are immune-mediated disorders that primarily affect small blood vessels of the airway and kidneys. Lung involvement, one of the hallmarks of microscopic polyangiitis and granulomatosis with polyangiitis, is associated with increased mortality and morbidity. In recent years, several retrospective series and case reports have described the association of interstitial lung disease (ILD) and ANCA vasculitis, particularly those positive for ANCA specific for myeloperoxidase. In the majority of these patients pulmonary fibrosis occurs concurrently or predates the diagnosis of ANCA vasculitis. More importantly, these studies have shown that ILD has an adverse impact on the long-term prognosis of ANCA vasculitis. This review focuses on the main clinical and radiologic features of pulmonary fibrosis associated with anti-neutrophil cytoplasmic antibodies. Major histopathology features, prognosis and therapeutic options are summarized.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ANCA; Interstitial lung disease; Microscopic polyangiitis; Pulmonary fibrosis

Mesh:

Substances:

Year:  2017        PMID: 28479484      PMCID: PMC6343660          DOI: 10.1016/j.autrev.2017.05.008

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  96 in total

Review 1.  American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-01-15       Impact factor: 21.405

2.  Four cases of anti-myeloperoxidase antibody-related rapidly progressive glomerulonephritis during the course of idiopathic pulmonary fibrosis.

Authors:  K Hiromura; Y Nojima; T Kitahara; K Ueki; A Maezawa; H Kawai; S Yano; T Naruse
Journal:  Clin Nephrol       Date:  2000-05       Impact factor: 0.975

3.  Fibrosing alveolitis predating microscopic polyangiitis.

Authors:  A Becker-Merok; J C Nossent; N Ritland
Journal:  Scand J Rheumatol       Date:  1999       Impact factor: 3.641

4.  Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients.

Authors:  L Guillevin; B Durand-Gasselin; R Cevallos; M Gayraud; F Lhote; P Callard; J Amouroux; P Casassus; B Jarrousse
Journal:  Arthritis Rheum       Date:  1999-03

5.  Microscopic polyangiitis presenting as idiopathic pulmonary fibrosis: is anti-neutrophilic cytoplasmic antibody testing indicated?

Authors:  I A Mansi; A Opran; D Sondhi; R Ayinla; F Rosner
Journal:  Am J Med Sci       Date:  2001-03       Impact factor: 2.378

6.  An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients.

Authors:  E Reinhold-Keller; N Beuge; U Latza; K de Groot; H Rudert; B Nölle; M Heller; W L Gross
Journal:  Arthritis Rheum       Date:  2000-05

7.  Antimyeloperoxidase-associated lung disease. An experimental model.

Authors:  P Foucher; P Heeringa; A H Petersen; M G Huitema; E Brouwer; J W Tervaert; J Prop; P Camus; J J Weening; C G Kallenberg
Journal:  Am J Respir Crit Care Med       Date:  1999-09       Impact factor: 21.405

8.  Subclinical alveolar bleeding in pulmonary vasculitides: correlation with indices of disease activity.

Authors:  A Schnabel; M Reuter; E Csernok; C Richter; W L Gross
Journal:  Eur Respir J       Date:  1999-07       Impact factor: 16.671

9.  Myeloperoxidase anti-neutrophil cytoplasmic autoantibodies (MPO-ANCA)-related rapidly progressive glomerulonephritis (RPGN) and pulmonary fibrosis (PF) with dissociated evolution.

Authors:  M Souid; N H Terki; D Nochy; D Hillion
Journal:  Clin Nephrol       Date:  2001-04       Impact factor: 0.975

10.  Acute cigarette smoke-induced connective tissue breakdown requires both neutrophils and macrophage metalloelastase in mice.

Authors:  Andrew Churg; Katalin Zay; Selena Shay; Changshi Xie; Steven D Shapiro; Robert Hendricks; Joanne L Wright
Journal:  Am J Respir Cell Mol Biol       Date:  2002-09       Impact factor: 6.914

View more
  26 in total

1.  Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: a prospective study and review of the literature.

Authors:  Andreina Manfredi; Marco Sebastiani; Stefania Cerri; Caterina Vacchi; Roberto Tonelli; Giovanni Della Casa; Giulia Cassone; Amelia Spinella; Pancaldi Fabrizio; Fabrizio Luppi; Carlo Salvarani
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

Review 2.  Pathogenesis of ANCA-Associated Pulmonary Vasculitis.

Authors:  Marco A Alba; J Charles Jennette; Ronald J Falk
Journal:  Semin Respir Crit Care Med       Date:  2018-11-07       Impact factor: 3.119

3.  Prevalence and Clinical Significance of Antineutrophil Cytoplasmic Antibodies in North American Patients With Idiopathic Pulmonary Fibrosis.

Authors:  Gabrielle Y Liu; Iazsmin Bauer Ventura; Natalia Achtar-Zadeh; Brett M Elicker; Kirk D Jones; Paul J Wolters; Harold R Collard; Ayodeji Adegunsoye; Mary E Strek; Brett Ley
Journal:  Chest       Date:  2019-06-07       Impact factor: 9.410

Review 4.  Autoimmunity in 2017.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

Review 5.  Genetics of ANCA-associated vasculitis: role in pathogenesis, classification and management.

Authors:  Giorgio Trivioli; Ana Marquez; Davide Martorana; Michelangelo Tesi; Andreas Kronbichler; Paul A Lyons; Augusto Vaglio
Journal:  Nat Rev Rheumatol       Date:  2022-09-15       Impact factor: 32.286

6.  The Role of Lung Colonization in Connective Tissue Disease-Associated Interstitial Lung Disease.

Authors:  Alberto Ricci; Alessandra Pagliuca; Morgana Vermi; Dario Pizzirusso; Marta Innammorato; Raffaele Sglavo; Francesco Scarso; Simonetta Salemi; Bruno Laganà; Roberta Di Rosa; Michela D'Ascanio
Journal:  Microorganisms       Date:  2021-04-27

Review 7.  Recent advances in the diagnosis and management of interstitial pneumonia with autoimmune features: the perspective of rheumatologists.

Authors:  Hong Ki Min; Se-Hee Kim; Sang-Heon Lee; Hae-Rim Kim
Journal:  Korean J Intern Med       Date:  2021-02-08       Impact factor: 2.884

8.  Utility of anti-neutrophil cytoplasmic antibody screening in idiopathic interstitial lung disease.

Authors:  Lee M Fidler; Sonja Kandel; Jolene H Fisher; Shikha Mittoo; Shane Shapera
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2021-06-28       Impact factor: 0.670

9.  Diffuse alveolar haemorrhage associated with subsequent development of ANCA positivity and emphysema in three young adults.

Authors:  Anna Stainer; Alex Rice; Anand Devaraj; Joseph Luke Barnett; Jacqueline Donovan; Maria Kokosi; Andrew Gordon Nicholson; Tom Cairns; Athol Umfrey Wells; Elisabetta Augusta Renzoni
Journal:  BMC Pulm Med       Date:  2019-10-24       Impact factor: 3.320

10.  Clinical implications of ANCA positivity in idiopathic pulmonary fibrosis patients.

Authors:  Guillermo Suarez-Cuartin; Maria Molina-Molina
Journal:  Breathe (Sheff)       Date:  2020-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.